Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$21.25 Million ≈ $669.40K USD) by net assets (NT$1.71 Billion ≈ $53.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Johnson Chemical Pharmaceutical Works Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Johnson Chemical Pharmaceutical Works Co (4747) total liabilities for a breakdown of total debt and financial obligations.

Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ci&T Inc NYSE:CINT	0.006x
Fast Food Indonesia Tbk JK:FAST	-8.197x
Strong H Machinery Technology (Cayman) Incorporation TW:4560	0.045x
Wanshih Electronic Co Ltd TWO:6134	-0.054x
Great Elm Capital Corp NASDAQ:GECC	-0.010x
Millie Seojae. KQ:418470	0.040x
XL Holdings Bhd KLSE:7121	-0.105x
Fortune Parts Industry Public Company Limited BK:FPI	0.098x

Annual Cash Flow Conversion Efficiency for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Johnson Chemical Pharmaceutical Works Co.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.70 Billion ≈ $53.68 Million	NT$62.88 Million ≈ $1.98 Million	0.037x	-54.95%
2023-12-31	NT$1.67 Billion ≈ $52.68 Million	NT$136.95 Million ≈ $4.31 Million	0.082x	-20.39%
2022-12-31	NT$871.66 Million ≈ $27.46 Million	NT$89.69 Million ≈ $2.83 Million	0.103x	+66.72%
2021-12-31	NT$848.24 Million ≈ $26.72 Million	NT$52.35 Million ≈ $1.65 Million	0.062x	-26.21%
2020-12-31	NT$858.20 Million ≈ $27.04 Million	NT$71.77 Million ≈ $2.26 Million	0.084x	-0.84%
2019-12-31	NT$847.97 Million ≈ $26.72 Million	NT$71.52 Million ≈ $2.25 Million	0.084x	+3.52%
2018-12-31	NT$836.53 Million ≈ $26.36 Million	NT$68.15 Million ≈ $2.15 Million	0.081x	+70.61%
2017-12-31	NT$835.43 Million ≈ $26.32 Million	NT$39.89 Million ≈ $1.26 Million	0.048x	-41.76%
2016-12-31	NT$832.41 Million ≈ $26.23 Million	NT$68.25 Million ≈ $2.15 Million	0.082x	+60.49%
2015-12-31	NT$821.60 Million ≈ $25.88 Million	NT$41.97 Million ≈ $1.32 Million	0.051x	-60.87%
2014-12-31	NT$635.01 Million ≈ $20.01 Million	NT$82.91 Million ≈ $2.61 Million	0.131x	-3.19%
2013-12-31	NT$583.53 Million ≈ $18.38 Million	NT$78.70 Million ≈ $2.48 Million	0.135x	+80.40%
2012-12-31	NT$386.30 Million ≈ $12.17 Million	NT$28.88 Million ≈ $909.94K	0.075x	-47.75%
2011-12-31	NT$353.39 Million ≈ $11.13 Million	NT$50.57 Million ≈ $1.59 Million	0.143x	+66.91%
2010-12-31	NT$324.45 Million ≈ $10.22 Million	NT$27.81 Million ≈ $876.26K	0.086x	-7.16%
2009-12-31	NT$311.47 Million ≈ $9.81 Million	NT$28.76 Million ≈ $906.10K	0.092x	--

About Johnson Chemical Pharmaceutical Works Co Ltd

TWO:4747 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$77.86 Million

NT$2.47 Billion TWD

Market Cap Rank

#20152 Global

#1182 in Taiwan

Share Price

NT$55.00

Change (1 day)

+0.36%

52-Week Range

NT$51.70 - NT$77.00

All Time High

NT$115.60